Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Studies on the stable inhibition of Na+ + K+-ATPase by cassaine

Producción científica: Articlerevisión exhaustiva

3 Citas (Scopus)

Resumen

Exposure of rat brain Na+ + K+-ATPase (ATP phosphohydrolase E.C. 3.6.1.3) to concentrations of cassaine greater than 1 × 10-4 M resulted in a poorly reversible inhibition of this enzyme. Inhibition did not require the presence of ATP and developed rapidly, but the final amount of inhibition observed was independent of time. The amount of inhibition observed at a given concentration of cassaine was reduced by increasing the concentration of membranes in the system. The inhibition of Na+ + K+-ATPase activity was associated with equivalent inhibition of the phosphorylation and (3H)-ouabain binding reactions of this enzyme, while the uninhibited enzyme was apparently kinetically normal. Concentrations of cassaine which produced this stable inhibition of Na+ + K+-ATPase had no effect on the Mg2+-activated ATPase or the NADH cytochrome-c-reductase activities of crude rat brain microsomal preparations. Cassaine inhibited the cholinesterase activity of rat brain microsomes with a Ki of about 5 × 10-5 M, but this inhibition was fully reversible. The poorly reversible inhibitory actions of cassaine, thus, appeared specific for Na+ + K+-ATPase. Because this stable pattern of inhibition of the Na+ + K+-ATPase by cassaine required drug concentrations at least one hundred-fold greater than those which produce positive inotropic effects, it appears unlikely that this pattern of Na+ + K+-ATPase inhibition is involved in the cardiotonic actions of this drug.

Idioma originalEnglish
Páginas (desde-hasta)59-68
Número de páginas10
PublicaciónEuropean Journal of Pharmacology
Volumen35
N.º1
DOI
EstadoPublished - ene 1976

Nota bibliográfica

Funding Information:
This work was supported by grants from the Michigan Heart Association, Grant HL 16055-01

Funding Information:
from the National Institutes of Health, and General Research Support Grant NIH RR 05623-04 from the College of Veterinary Medicine, Michigan State University, from the National Institutes of Health. The authors would like to thank Dr. Frank Welsch for helpful discussions and Mrs. Marilyn Turnbow for excellent technical assistance. Particular thanks are due to Doctor Schliep of E. Merck, Ltd. for making the original sample of cassaine available to us, and to Dr. O. Wasserman of Christian Albrechts University who provided us with a comparative sample of cassaine.

Financiación

This work was supported by grants from the Michigan Heart Association, Grant HL 16055-01 from the National Institutes of Health, and General Research Support Grant NIH RR 05623-04 from the College of Veterinary Medicine, Michigan State University, from the National Institutes of Health. The authors would like to thank Dr. Frank Welsch for helpful discussions and Mrs. Marilyn Turnbow for excellent technical assistance. Particular thanks are due to Doctor Schliep of E. Merck, Ltd. for making the original sample of cassaine available to us, and to Dr. O. Wasserman of Christian Albrechts University who provided us with a comparative sample of cassaine.

FinanciadoresNúmero del financiador
Michigan Heart AssociationHL 16055-01
National Institutes of Health (NIH)NIH RR 05623-04
Michigan State University

    ASJC Scopus subject areas

    • Pharmacology

    Huella

    Profundice en los temas de investigación de 'Studies on the stable inhibition of Na+ + K+-ATPase by cassaine'. En conjunto forman una huella única.

    Citar esto